Archer-Daniels to Buy Pfizer Citric Acid Unit
- Share via
NEW YORK — Pfizer Inc. said it has reached an agreement to sell the company’s citric acid business to Archer-Daniels-Midland Co.
Terms were not disclosed, but Pfizer said the divestiture will yield “a profit” for the company.
Pfizer’s sales of citric acid, a key chemical component in the food beverage and pharmaceutical industries, amounted to more than $180 million in 1989.
Pfizer’s main citric acid production sites are in Southport, N.C., and Ringaskiddy, Ireland, and have 700 employees.
The health-care and specialty chemicals company said it would retain its Groton, Conn., citric acid plant.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
